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Abstract  
Public health decision makers value interventions for their impacts on overall health and 
health inequality. Distributional cost-effectiveness analysis (DCEA) incorporates health 
inequality concerns into economic evaluation by accounting for how parameters, such as 
effectiveness, differ across population groups. Good understanding of how and when 
accounting for socioeconomic differences between groups affects the assessment of 
intervention impacts on overall health and health inequality could inform decision makers 
where DCEA would add most value. 
 
We interrogated two DCEA models of smoking and alcohol policies, using first national level 
and then Local Authority level information on various socioeconomic differences in health 
and intervention use. Through a series of scenario analyses, we explored the impact of 
altering these differences on the DCEA results. 
 
When all available evidence on socioeconomic differences was incorporated, provision of a 
smoking cessation service was estimated to increase overall health and increase health 
inequality, while the screening and brief intervention for alcohol misuse was estimated to 
increase overall health and reduce inequality. Ignoring all or some socioeconomic differences 
resulted in minimal change to the estimated impact on overall health in both models, 
however, there were larger effects on the estimated impact on health inequality. Across the 
models there were no clear patterns in how the extent and direction of socioeconomic 
differences in the inputs translated into the estimated impact on health inequality. Modifying 
use or coverage of either intervention so that each population group matched the highest level 
improved the impacts to a greater degree than modifying intervention effectiveness. When 
local level socioeconomic differences were considered, the magnitude of impacts was altered; 
in some cases, the direction of impact on inequality was also altered.  
 
Keywords  
Distributional cost-effectiveness analysis, economic evaluation, health inequality, public 
health 
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Introduction  1 
Cost-effectiveness analysis (CEA) is routinely employed to inform health care resource 2 
allocation decisions [1]. When allocating resources in public health, decision makers often 3 
consider how potential policies would improve population health and reduce unfair health 4 
inequalities (i.e., reduce the perceived unfairness of the distribution of health across the 5 
population) [2, 3]. The decision about whether to fund a public health intervention is 6 
therefore informed by its impact on the distribution of health across the population: both in 7 
terms of its sum total and the extent of inequality between relevant population groups. The 8 
distributional cost-effectiveness analysis (DCEA) framework considers how interventions 9 
impact the distribution of health [4, 5]. It is used to estimate the net impact of an intervention 10 
on overall health and in each population group of interest, and to examine the trade-offs 11 
between improving overall health and reducing health inequality. 12 
 13 
To perform DCEA, the evaluation of costs and consequences of alternative interventions 14 
must account for differences between equity relevant groups [6]. This requires evidence on 15 
how the parameters of the evaluation, e.g., the value of inputs to a decision analytic model, 16 
vary between groups. Lack of evidence on between-group differences can make it 17 
challenging to conduct a formal evaluation. Even when the evidence is available, a DCEA is 18 
more complex than a standard CEA and policy makers may lack the resources to undertake 19 
DCEA in all circumstances. Developing greater understanding of how and when accounting 20 
for socioeconomic differences in model inputs affects the final estimate of the intervention 21 
impact on the distribution of health could enable us to identify a subset of parameters that are 22 
sufficient to inform the intervention impact, which may make it possible to simplify the 23 
DCEA process, and help decision makers and analysts to know where DCEA would add most 24 
and when to gather further evidence on socioeconomic differences. 25 
 26 
When appraising how an intervention impacts on health inequality, a common question is 27 
whether anything can be done to modify either the intervention itself or the way in which it is 28 
delivered in order to make it benefit population groups more fairly [7]. For example, if uptake 29 
of the intervention is socially patterned, policy makers may ask whether it is worthwhile 30 
investing in actions that increase uptake in lower socioeconomic groups. A breakdown 31 
showing how eliminating socioeconomic differences in each model input could alter the final 32 
distribution of health could help direct efforts to answer such questions. 33 
 34 
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In the UK, Local Authorities have the responsibility of making decisions about which public 1 
health interventions to fund for their local population. However, many appraisals of the 2 
potential interventions are performed and reported at a national level [8]. The extent of 3 
socioeconomic differences in model inputs can vary between settings, e.g., the smoking 4 
prevalence by socioeconomic status within Local Authorities differs from the overall national 5 
figure [9]. The population distribution between socioeconomic groups may also differ 6 
between settings. Consequently, evaluating the intervention impact based on national level 7 
estimates may not be informative for the impact that would be expected at a local level. 8 
Therefore, it may be relevant to local decision makers to understand how local level variation 9 
will alter estimated policy impacts compared to the national level estimates.  10 
 11 
In this study, we adapted two existing DCEA models of public health interventions to address 12 
four broad questions:  13 
(a) how influential is failing to consider specific socioeconomic differences on the estimated 14 
intervention impacts on overall health and health inequality?;  15 
(b) which modifiable intervention characteristics represent the most valuable targets to 16 
mitigate socioeconomic differences in intervention impact?;  17 
(c) how generalisable are conclusions about the intervention impacts on overall health and 18 
health inequality between areas with different characteristics?;  19 
(d) what conclusions can we draw about the generalisability of the results of the two studies 20 
to other interventions or disease areas? 21 
 22 
Methods 23 
Overview 24 
DCEA of smoking and alcohol policies were conducted using two existing models [10, 11]. 25 
Health benefits were expressed as quality-adjusted life years (QALYs) and costs in pounds 26 
sterling (£, 2018 price year) under a National Health Service (NHS) and personal social 27 
services perspective. An annual discount rate of 3.5% was applied to both benefits and costs 28 
in accordance with National Institute for Health and Care Excellence (NICE) guidance [12]. 29 
The NICE cost-effectiveness threshold of £20,000 per QALY was used [13]. 30 
 31 
In both models, we considered inequality between population groups defined according to the 32 
level of socioeconomic deprivation LQLQGLYLGXDOV¶DUHDRIUHVLGHQFH, i.e., Index of Multiple 33 
Deprivation (IMD) [14]. IMD is an area-level weighted composite index combining 34 
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information on income, employment, health, education, housing, crime and living 1 
environment for a geographical area of approximately 1,500 residents [14]. As IMD is not an 2 
individual-level measure, there will be variation in the socioeconomic status of residents 3 
within each area and even highly deprived areas will have some high socioeconomic status 4 
inhabitants. The population was divided into five groups defined by quintile of IMD, and 5 
differences in model inputs across IMD quintiles were characterised. Both models estimate 6 
the amount by which policies change health within each population group. Summing over the 7 
change in health across all five groups gives the total change in population health, expressed 8 
as population incremental net health benefit (NHB) [1].  9 
 10 
&RQVLGHULQJWKHJHQHUDOSRSXODWLRQ¶VSUHIHUHQFHIRUUHGXFLQJKHDOth inequality between rich 11 
DQGSRRUJURXSVZHFDQSUHVHQWWKHWRWDOSRSXODWLRQKHDOWKDVWKHµHTXDOO\GLVWULEXWHG12 
HTXLYDOHQW('(KHDOWK¶7RFDOFXODWHWKLV('(KHDOWKWKHVWUHQJWKRISUHIHUHQFHIRU13 
reducing inequality is used as a weight to provide a weighted total population health. EDE 14 
health can be interpreted as the amount of health distributed equally to all population groups 15 
that would be considered equally valuable to the distribution being evaluated [4]. Given the 16 
preference for reducing existing health inequalities, the EDE is lower than the population 17 
health, and the difference describes the amount of overall health that people would be willing 18 
to sacrifice to achieve an equal distribution. Alternatively, the difference between the EDE 19 
and the total population health can be interpreted as the welfare cost of health inequality, as it 20 
represents the social value that could be gained if health were redistributed equally. A policy 21 
that leaves the total population health unchanged but reduces the difference in health between 22 
population groups will increase the EDE health. We expressed the policy impact on health 23 
inequality using the difference between how policies alter the EDE health (which increases 24 
with total health and with reduction of inequality in health) and how policies alter total health 25 
(incremental NHB).  26 
 27 
Scenario analyses were performed to explore how altering socioeconomic differences in 28 
model inputs affects the estimated impacts.  29 
 30 
Models 31 
The smoking model is a cohort Markov model that assesses the cost-effectiveness of nicotine 32 
replacement therapies in adult smokers (18-75 years) over a lifetime horizon [10]. These 33 
therapies are accessed through primary care [10]. The Markov model includes three mutually 34 
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exclusive health states: smokers, former smokers and death. Smokers and former smokers 1 
differ in mortality risk, health-related quality of life (HRQoL) and risk of developing six 2 
smoking-related diseases, modelled as events with impact on costs and HRQoL. The 3 
Sheffield Alcohol Policy Model is a hybrid simulation consisting of two linked models that 4 
evaluates the cost-effectiveness of screening and brief interventions (SBIs) to reduce alcohol 5 
misuse [11]. The first part of the model takes a baseline population of individual drinkers and 6 
simulates receipt of SBIs and the resulting age-adjusted trends in alcohol consumption over a 7 
20-year time horizon. The second part of the model aggregates these individuals into cohorts 8 
based on age, gender, IMD quintile and baseline drinking level. The model simulates 45 9 
alcohol-related health conditions, which are linked to associated mortality rates and hospital 10 
admissions.  11 
 12 
In this study, we focus on the provision of e-cigarette in the smoking model and the strategy 13 
of delivering SBIs to all patients when registering with a new primary care practice µ1H[W14 
5HJLVWUDWLRQ¶ in the alcohol model, both FRPSDUHGWRµQRLQWHUYHQWLRQ¶  15 
 16 
Impact on overall health 17 
The models estimate the incremental direct health benefits and incremental healthcare costs 18 
of the interventionsFRPSDUHGWRµQRLQWHUYHQWLRQ¶specific to smokers and alcohol users in 19 
each IMD quintile. Zero health benefit accrues to people who are not eligible for the 20 
interventions (i.e. non-smokers and those who do not misuse alcohol). The incremental costs 21 
are converted into health opportunity costs, i.e., the health that would have been achieved if 22 
those resources had been used for other purposes, using the NICE cost-effectiveness 23 
threshold. The health benefits of making resources available for other purposes will not fall 24 
equally to all socioeconomic groups. Research has shown that a greater proportion of the 25 
benefit from changes in NHS spending goes to more deprived groups. Deprived groups 26 
therefore lose out most when resources are appropriated for specific policies, or conversely 27 
stand to gain the most when policies are cost saving and release resources [15]. For each IMD 28 
quintile, the health opportunity costs are subtracted from the direct health benefits to provide 29 
the distribution of the incremental net health benefit (iNHB), i.e. the change in health by 30 
population group. The impact on overall health is the population iNHB, i.e., the sum of iNHB 31 
across all quintiles. 32 
 33 
 34 
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Impact on health inequality 1 
The baseline distribution of health is the distribution of quality-adjusted life expectancy 2 
(QALE) [16], which combines differences in life expectancy between groups with differences 3 
in quality of life between groups. The iNHB in each IMD quintile estimated for each 4 
intervention is added to the baseline QALE in each IMD quintile to estimate the predicted 5 
distribution of QALE following the implementation of the intervention. The QALE 6 
distribution is summarised as EDE health by using the Atkinson index, with an inequality 7 
aversion parameter derived from a UK population survey [17]. The Atkinson inequality 8 
aversion parameter describes the strength of preference for reducing relative inequality in 9 
health. When applied to calculate the EDE, it assigns higher weight to health improvements 10 
in more deprived groups that have lower baseline QALE, and a lower weight to health 11 
improvements in less deprived groups with greater baseline QALE [18]. The change from the 12 
EDE in the baseline health to the EDE of the health with the intervention, i.e., incremental 13 
EDE (iEDE), encompasses the impact of the intervention on both overall health and health 14 
inequality. To isolate the impact on health inequality, we look at the difference between iEDE 15 
and iNHB, with positive value showing that the intervention reduces the cost of health 16 
inequality. We illustrate these calculations for the smoking model in Box 1. 17 
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Box 1. Smoking cessation model 
1. Extract the incremental direct health benefits (a) and the incremental healthcare costs (b) of e-cigarette vs µQRLQWHUYHQWLRQ¶from the smoking DCEA 
model for each IMD quintile in England.  
 
2. Sum the incremental costs (c) and then convert to health opportunity costs at a rate of £20,000 per QALY (d),  
      i.e., £ (-156,391,946)/£20,000 = -7,820 QALYs. 
 
3. Use the proportion of the health opportunity costs borne by each IMD quintile (e) to calculate the size of the health opportunity costs in each IMD 
quintile (f), e.g., health opportunity costs for IMD1 is -7,820*0.26 = -2,033 QALYs.  
 
4. Calculate the incremental NHB for each IMD quintile (g) by subtracting health opportunity costs from the incremental direct health benefits, e.g., 
incremental NHB for IMD1 is 6,560 - (-2,033) = 8,593 QALYs.  
 
5. Calculate the incremental NHB per capita by IMD quintile (i) using the distribution of the adult population of England (h), e.g., IMD1, the 
individual incremental NHB is 8,593/8,307,456 = 0.0010 QALYs. 
 
6. Add the individual incremental NHB to the baseline QALE (j) to calculate the QALE with the intervention by IMD quintile (k).  
 
7. Calculate EDE for the baseline QALE distribution (l) and the QALE distribution with the intervention (m) using the Atkinson social welfare 
function with an inequality aversion parameter, İ, of 10.95.  
                                                                 
      hi= individual QALE for a person in IMD quintile i 
      N= total population size 
      İ= Atkinson inequality aversion parameter  
 
8. Calculate the population incremental EDE with the intervention (n), i.e., the difference of population EDE with the intervention and the population 
baseline EDE, where the population EDE is multiplying EDE by total population size.  
 
9. Calculate the population incremental NHB with the intervention (o), i.e., sum incremental NHB across all quintiles. 
 
10. Calculate how the intervention changes health inequality (iEDE-iNHB) (p), i.e., 70,002 - 80,782 = -10,780 QALYs. 
9 
 
 
 
 
  IMD1 
 (most deprived) 
IMD2  IMD3 IMD4 IMD5  
(least deprived) 
1. (a) Incremental direct health benefits1,QALYs 6,560 15,619 13,201 19,350 18,233 
 (b) Incremental costs1, £ -12,544,948 -32,507,825 -29,016,052 -42,924,171 -39,398,949 
2. (c) Total incremental costs (sum of b), £ -156,391,946 
 (d) Total health opportunity costs (c/20,000), QALYs -7,820 
3. (e) Proportion of health opportunity costs2 0.26 0.22 0.22 0.16 0.14 
 (f) Health opportunity costs (d*e), QALYs -2,033 -1,720 -1,720 -1,251 -1,095 
4. (g) Incremental NHB (a-f), QALYs 8,593 17,339 14,921 20,601 19,328 
5. (h) Population size3 8,307,456 8,863,275 8,790,681 8,657,257 8,376,275 
 (i) Individual incremental NHB (g/h), QALYs 0.0010 0.0020 0.0017 0.0024 0.0023 
6. (j) Baseline QALE (no intervention)4 64.7 68.5 70.6 73.6 75.6 
 (k) QALE with e-cigarette (i+j) 64.7010 68.5020 70.6018 73.6024 75.6023 
7. (l) Baseline EDE, QALYs  69.465 
8. (m) EDE with the intervention, QALYs 69.467 
 (n) Population incremental EDE  (m*sum of h-l*sum of h), QALYs 70,002 
9. (o) Impact on overall health (sum of g)  80,782 
10. (p) Impact on health inequality (n-o) -10,780 
1calculated using results from the model. 
2Love-Koh J et al. Estimating Social Variation in the Health Effects of Changes in Healthcare Expenditure. Medical Decision Making 2020. 
3Office for National Statistics (ONS) mid-year population estimates 2017. 
4Love-Koh J et al. The Social Distribution of Health: Estimating Quality-Adjusted Life Expectancy in England. Value in Health 2015. 
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Inequality in model inputs 1 
Model inputs in which we reflect socioeconomic differences were categorised into four 2 
groups: background parameters, behaviours, health consequences of behaviour, and 3 
intervention characteristics. The level and direction of inequality in these model inputs 4 
between population groups are summarised using the concentration index [19] (Table 1). It 5 
ranges from -1 to 1, with negative values demonstrating higher values of the input in more 6 
deprived groups, while positive values demonstrate higher values in less deprived groups. 7 
The following sections give an overview of each category of input, and more detailed 8 
information is available in the Appendix.  9 
 10 
Background parameters  11 
Background parameters reflect the level of health that would be observed without 12 
interventions, including the baseline QALE [16] and health opportunity costs [15]. Baseline 13 
QALE is higher in less deprived areas and more health opportunity costs fall on residents in 14 
more deprived areas (Table 1). 15 
 16 
Behaviours  17 
Behaviours including the smoking prevalence and the abstention from drinking by IMD 18 
quintile were based on survey data. The smoking model incorporated the proportion of 19 
smokers in each IMD quintile [9]. The alcohol model incorporated socioeconomic differences 20 
in abstention from drinking, average weekly consumption and peak day drinking. People in 21 
more deprived groups are more likely to smoke but less likely to drink, drink less on average 22 
anGµELQJH¶GULQNDWORZHUOHYHOVTable 1). 23 
 24 
Health consequences of behaviour  25 
Health consequences of behaviour include mortality, related diseases and HRQoL. In the 26 
smoking model, the annual mortality rates for smokers (Figure S1) were based on general 27 
population all-cause mortality [20], proportion of smokers, former smokers and non-smokers 28 
[21], and the increased relative risk of death for smokers [22]. Mortality in the alcohol model 29 
was modelled separately by health condition, including alcohol-related mortality and all other 30 
causes combined (Figure S2). In both models, there is a higher death rate in more deprived 31 
areas (Table 1). 32 
 33 
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The socioeconomic difference in the smoking-related diseases was estimated using the 1 
average population incidence [21] and the relative risk between IMD quintiles of developing 2 
smoking-related disease [23]. We assumed that the middle IMD quintile, i.e., IMD3, was 3 
represented by the average incidence of smoking-related disease, and then applied relative 4 
risks to estimate incidence in other IMD quintiles. Data on alcohol-related diseases were 5 
obtained from individual hospital records. People living in more deprived areas are more 6 
likely to develop smoking- and alcohol-related diseases (Table 1). 7 
 8 
The smoking model included HRQoL for smokers and former smokers by IMD quintile, 9 
estimated from survey data by linear regression (details available in Table S6). People living 10 
in less deprived areas tend to have higher HRQoL (Table 1). The same decrement in HRQoL 11 
for each smoking-related disease was applied across all IMD quintiles as no evidence was 12 
identified to inform differential effects. In the alcohol model, separate HRQoL values were 13 
applied for each alcohol-related health condition for each age-sex subgroup [24], with no 14 
evidence available for differences by IMD quintile. 15 
 16 
In both models, the healthcare costs associated with disease-related events are not 17 
differentiated by IMD, as we did not identify evidence that would let us impose a different 18 
healthcare costs per health event by deprivation. 19 
 20 
Intervention characteristics 21 
Socioeconomic differences in intervention impact were incorporated in both models. In the 22 
smoking model, the socioeconomic difference in effectiveness (Table S7) was incorporated 23 
assuming that the middle quintile was represented by the average quit rate for the intervention 24 
[25], and then applying the relative risk of quitting between IMD quintiles [26]. The 25 
socioeconomic difference in intervention uptake was based on the proportion of smokers 26 
supplied with an NHS Stop Smoking Service [21]. In the alcohol model, we did not consider 27 
socioeconomic difference in the intervention effect because of the lack of clear evidence, but 28 
incorporated the difference in the access to the intervention. It consists of an initial step 29 
where individuals attending primary care are selected to be screened, informed by the rates at 30 
which individuals register with new GP practices [27] (Table S8) and a second step where 31 
those identified as drinking at potentially risky levels (screen positive) receive an 32 
intervention, estimated using the Alcohol Toolkit Study [28] (Table S9). The concentration 33 
indices show higher effectiveness and uptake of smoking cessation in less deprived areas, 34 
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while those for alcohol interventions show higher screening coverage and screening positive 1 
in more deprived areas (Table 1).  2 
 3 
Local Authority level inputs 4 
To contrast national level results to local area results, we selected two Local Authorities with 5 
distinct socioeconomic profiles (smoking: York and Sheffield; alcohol: Liverpool and 6 
Trafford). More residents in York and Trafford live in the least deprived quintile compared 7 
to England as a whole, while in Sheffield and Liverpool more residents living in the most 8 
deprived quintile (Figures S3 & S4) [29]. The smoking model used local information on 9 
smoking prevalence only (Figure S5), while the alcohol model included local information on 10 
mortality and morbidity rates from alcohol-related diseases, the abstention of drinking and 11 
mean weekly alcohol consumption (Figure S6). The remaining differences for other 12 
parameters were based on national level figures in the absence of relevant data.  13 
 14 
Analysis 15 
A series of scenario analyses were performed to explore the impact of altering the 16 
socioeconomic differences in model inputs on DCEA results, corresponding to the four 17 
questions raised in introduction. The intervention impacts estimated in each scenario analysis 18 
ZHUHFRPSDUHGWRWKHµbase case¶HVWLPDWHVZKLFKconstitute the results when all the 19 
socioeconomic differences in the model inputs mentioned previously are incorporated. We 20 
DVVXPHWKDWWKHµbase case¶UHSUHVHQWWKHµEHVW¶HVWLPDWHRIWKHLQWHUYHQWLRQLPSDFWVThe 21 
µbase case¶ results and the results of each scenario analysis are presented as scatter plots on 22 
the health equity impact plane [3]. The differences from the µbase case¶ reflect in which 23 
direction and to what extent each scenario affects how well the each model estimates 24 
intervention impact on the distribution of health.    25 
 26 
Question (a): all model inputs were set to the population average value in all IMD quintiles. 27 
This is equivalent to a standard CEA in which only the average population impact on overall 28 
health is calculated. It was expected that ignoring all socioeconomic differences would have 29 
minimal effect on the estimated impact on overall health but a larger effect on the impact on 30 
health inequality. We then excluded socioeconomic difference in one model input at a time 31 
and compared the model outputs with the µbase case¶ estimates. This illustrates to what 32 
degree ignoring socioeconomic difference in each model input would affect the estimates of 33 
impacts on overall health and health inequality. 34 
13 
 
 1 
Question (b): the model inputs we identified as potentially modifiable intervention 2 
characteristics were set to the highest level achieved in any of the groups to explore the value 3 
of µOHYHOOLQJXS¶WReliminate the differences. In the smoking model, all groups were assumed 4 
to have the highest probability of quitting smoking and highest intervention uptake rate. In 5 
the alcohol model, the alcohol misuse screening coverage was assumed to go up to the 6 
highest level across all quintiles within the same age-VH[JURXSµDJH-VH[PD[¶DQGDOVRWKH7 
highest across all age-sex-deprivation groups µJOREDOPD[¶. 8 
 9 
Question (c): the model inputs reflecting socioeconomic differences at local level were 10 
incorporated to estimate the µbase case¶UHVXOWVIRUWZR/RFDO$XWKRULWLHVLQHDFKPRGHO7R11 
enable comparisons across areas that differ in population size, the intervention impacts for 12 
100,000 adults were presented. 7KHµbase case¶UHVXOWVat local level were compared between 13 
Local Authorities and to the results for the nation as a whole.  14 
 15 
Question (d): as the two models evaluated different interventions in different disease areas, 16 
we compared the results of abovementioned analyses in the two models to assess how the 17 
conclusions might vary between models. Additionally, for analyses in addressing question 18 
(a), we rearranged the results by plotting the changes in the estimated impacts against the 19 
concentration index of the model input which was ignored and then compared these across 20 
both models to explore the possible patterns between the extent of inequality of model inputs 21 
and the variations in estimated impacts on overall health and health inequality.  22 
 23 
Results 24 
The results of base case and scenario analyses are summarised in Table 2 and plotted in 25 
Figure 1 and Figure 2. These base case estimates indicate that cRPSDUHGWRµQRLQWHUYHQWLRQ¶26 
e-cigarette was estimated to increase overall health (iNHB=80,782 QALYs), but increase 27 
health inequality (iEDE-iNHB=-10,780 QALYs), while the alcohol µNext Registration¶ 28 
strategy was estimated to increase overall health (iNHB=4,336 QALYs) and reduce 29 
inequality (iEDE-iNHB=444 QALYs) (Table 2).  30 
 31 
14 
 
(a) How influential is failing to consider socioeconomic differences? 1 
Ignoring socioeconomic differences in all model inputs 2 
Compared to the base case, ignoring socioeconomic differences in all model inputs reduced 3 
the amount by which the interventions were predicted to increase overall health (smoking 4 
model: -272 QALYs, -0.34%; alcohol model: -253 QALYs, -5.83%) (Table 2); e-cigarette 5 
was predicted to have no effect on inequality and the alcohol µ1H[W5HJLVWUDWLRQ¶VWUDWHJ\ZDV6 
predicted to increase inequality (Table 2 & Figure 1).  7 
 8 
Ignoring the socioeconomic difference in one model input at a time 9 
Compared to the base case, in the smoking model, ignoring the socioeconomic difference in 10 
smoking prevalence resulted in the greatest increase in the estimated overall health impact 11 
(4,902 QALYs, 6.07% greater than the total in base case), while ignoring the difference in 12 
intervention effectiveness resulted in the greatest reduction (-3,564 QALYs, -4.39%) (Table 13 
2). In the alcohol model, ignoring the socioeconomic difference in mean alcohol consumption 14 
resulted in the greatest increase in the estimated overall health impact (756 QALYs, 17.44%), 15 
while ignoring the difference in drinking prevalence resulted in the greatest reduction (-389 16 
QALYs, -8.97%) (Table 2). 17 
 18 
In the smoking model, ignoring the socioeconomic differences in health opportunity costs, 19 
smoking prevalence and risk of smoking-related diseases increased the extent by which the 20 
intervention was estimated to increase inequality, while ignoring socioeconomic differences 21 
in baseline QALE, mortality risks, HRQoL, effectiveness and uptake reduced this extent 22 
(with removal of the socioeconomic difference in uptake making e-cigarette inequality-23 
reducing), compared to the base case (Figure 1a). In the alcohol model, ignoring the 24 
socioeconomic differences in average weekly consumption, peak day consumption, screening 25 
coverage, likelihood of screening positive and the health opportunity costs increased the 26 
extent by which the intervention was estimated to reduce inequality, while ignoring the 27 
socioeconomic differences in abstention from drinking, alcohol-related diseases and mortality 28 
rates reduced it (with removal of the socioeconomic difference in morbidity making the 29 
strategy inequality-increasing) (Figure 1b). 30 
 31 
(b) Which modifiable intervention characteristics represent the most value? 32 
Levelling up effectiveness and uptake of smoking cessation intervention increased the 33 
estimated overall health impact by 7,448 QALYs (9.22%) and 28,875 QALYs (35.74%), 34 
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respectively, and reduced the extent by which it was predicted to increase inequality, with 1 
levelling up uptake making e-cigarette inequality-reducing, compared to the base case (Table 2 
2 & Figure 2a). 3 
 4 
In the alcohol model LQFUHDVLQJFRYHUDJHRI WKHµ1H[W5HJLVWUDWLRQ¶VWUDWHJ\WR the age-sex 5 
specific maximum level increased the estimated improvement in overall health by 480 6 
QALYs (11.07%) and increased the extent by which it was estimated to reduce inequality, 7 
and increasing the coverage to population maximum level increased the estimated 8 
improvement in overall health by 13,556 QALYs (312.64%) and reduced health inequality to 9 
a much greater extent (Table 2 & Figure 2b). 10 
 11 
(c) How generalisable are conclusions between settings?  12 
Results per 100,000 adults for each setting are presented in Figure 3. In the smoking model, 13 
using local level evidence, e-cigarette was estimated to improve overall health in England, 14 
York and Sheffield with different magnitudes of impacts (Figure 3a); it was estimated to 15 
increase inequality in Sheffield and England but reduce inequality in York (Figure 3a). The 16 
alcohol µ1H[W5HJLVWUDWLRQ¶VWUDWHJ\was estimated to increase overall health and reduce 17 
inequality in England and both Local Authorities, but the greatest increase in overall health 18 
was in Liverpool and the greatest reduction in health inequality was in Trafford (Figure 3b).  19 
 20 
(d) How generalisable are the results between models and disease areas? 21 
The concentration index of each model input and the amount by which ignoring it alters the 22 
estimated intervention impacts on overall health and health inequality is plotted in Figure S7 23 
and Figure 4, respectively. In both models, there was no clear pattern relating inequality of 24 
the model input to how it alters the estimated impact on overall health (Figure S7). In the 25 
smoking model, there was a positive correlation between the concentration index and the 26 
impact of ignoring socioeconomic differences in that input on the estimated health inequality 27 
impact, compared to the base case (Figure 4a). Ignoring the socioeconomic differences in 28 
model inputs that are more concentrated on the less deprived (positive concentration index 29 
values) increases the amount by which the intervention is estimated to reduce inequality 30 
while ignoring the socioeconomic differences in model inputs concentrated on the more 31 
deprived results (negative concentration index values) decreases it. However, this pattern was 32 
not clearly observed in the alcohol model (Figure 4b).   33 
 34 
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Discussion  1 
Evidence on how the impacts of policies vary across population groups is vital to inform 2 
decisions that rest on consideration of impacts on overall health and health inequality. By 3 
interrogating two different DCEA models that feature opposite effects on inequality, we 4 
demonstrated how the evidence for socioeconomic differences in policy impact could be 5 
evaluated within a DCEA framework, which represents a form of stratified cost-effectiveness 6 
analysis. Good understanding of how and when accounting for socioeconomic differences 7 
between groups affects the assessment of intervention impacts on overall health and health 8 
inequality could advice researchers whether it is possible to simplify the DCEA process and 9 
inform decision makers where DCEA would add most value. 10 
 11 
First, we found that failing to consider socioeconomic differences would affect the estimated 12 
policy impacts to a different degree between the two models. It has a more minor influence 13 
on the estimated overall health impact in the smoking model, and a greater influence in the 14 
non-linear alcohol model (smoking model: -0.21% alcohol model: -5.83%). As anticipated, it 15 
greatly affected the estimated impact on health inequality, influencing not only the magnitude 16 
but also the direction of effect (smoking: increase inequality to no effect; alcohol: reduce 17 
inequality to increase inequality). Ignoring socioeconomic differences in just one input can 18 
have a substantial effect on the results, but we found no clear relationship that might predict 19 
which model inputs are most influential.  20 
 21 
Second, levelling up modifiable intervention characteristics to the highest level achieved in 22 
any subgroup would improve estimated health inequality impact to the direction that favours 23 
the interventions. It also increases the estimated overall health impact, so it would not impose 24 
a trade-off between improvement in overall health and reduction in inequality. 25 
Socioeconomic variation in smoking cessation uptake appears a more valuable target for 26 
modification than socioeconomic variation in effectiveness. This could inform decision 27 
makers where to focus efforts to make policies benefit population groups more fairly. It 28 
should be noted that such efforts usually attract additional costs, and further analysis would 29 
be needed to explore whether the benefits are worthwhile.  30 
 31 
Third, the magnitude of impacts on overall health and health inequality at one Local 32 
Authority was different compared to that at another Local Authority or the nation as a whole. 33 
In the smoking model, the direction of the impact was also different (e-cigarette was 34 
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estimated to reduce inequality in York, but to increase inequality measured across England 1 
and Sheffield). The inconsistency in the policy impacts between settings is likely to be driven 2 
by the different deprivation structures of the populations and the local level socioeconomic 3 
differences. This suggests that caution should be taken when generalising recommendation of 4 
interventions from national level to Local Authorities, and between Local Authorities 5 
differing in deprivation structure of the population and other model inputs. Prioritisation and 6 
local level decision making could be better supported by conducting and reporting analyses 7 
that reflects differences relevant to the local context. 8 
 9 
The conclusions that can be drawn from this study are limited as it is based on only two 10 
models. Although both decision models have been used to support real resource allocation 11 
decisions in the UK, the base case results may omit potential socioeconomic differences in 12 
inputs where evidence was not available. For example, if disease-related events require more 13 
resource use for treatment, or impose a greater quality of life decrement, in more deprived 14 
groups, the socioeconomic differences in healthcare costs and health-related quality of life 15 
would be underestimated. In view of this, sensitivity analyses of more DCEA models can be 16 
combined with the results from our analysis to further our understanding of how influential 17 
considering socioeconomic differences in different types of model input is on the estimated 18 
policy impacts. We have not considered alternative interventions or designs of the 19 
interventions (e.g. extra efforts on targeting disadvantaged groups), which would be expected 20 
to have alternative impacts on inequalities, but there is scope for the use of DCEA and other 21 
methods to help inform how best to design interventions to impact on inequalities. 22 
Additionally, the evidence on socioeconomic differences in model inputs is associated with 23 
uncertainty. The smoking model incorporated this uncertainty, which could be analysed with 24 
a probabilistic sensitivity analysis, to provide credible intervals around estimated policy 25 
impacts. However, the computing time for the individual simulation alcohol model was 26 
already high and did not allow for probabilistic sensitivity analysis. Consequently, we did not 27 
compare the influence of uncertainty across the two models.  28 
 29 
The results presented in this study indicate that between-group differences in patterns of 30 
disease, intervention efficacy and intervention use can combine and interact in a complex 31 
manner and produce results that are difficult to predict. Thus, a formal analysis of inequality 32 
impacts, such as that provided by a full DCEA, can be beneficial in guiding resource 33 
allocation decisions. In practice, the decision on whether to conduct a DCEA or some other 34 
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form of stratified analysis may be informed by qualitative approaches, similar to those used 1 
in the integrated health technology assessment (HTA) process [30]. A number of other 2 
methods have been proposed in the literature for including health inequality concerns in 3 
economic evaluation, for example the extended CEA [31], but these methods would rely on 4 
the same evidence on socioeconomic differences utilised here [5] and do not use inequality 5 
indices to explicitly analyse trade-offs between improving health and reducing health 6 
inequality. Although we have seen in this study that additional work is needed to conduct the 7 
DCEA and the approach would increase complexity and introduce uncertainty, the 8 
applications of DCEA have shown that it is feasible to implement within a typical HTA 9 
process and the skills required lie within the capabilities of analysts currently conducting 10 
CEA [4]. The trade-offs between health improvement and inequality reduction, informed by a 11 
full DCEA, would assist decision makers to clarify and quantify the nature of their inequality 12 
concerns and provide better ways of communicating findings to wider audiences [4].  13 
 14 
Conclusions 15 
By conducting two case studies, one assessing smoking cessation intervention and the other 16 
assessing alcohol screening and brief intervention, we found that conclusions about their 17 
impact on health inequality are strongly influenced by socioeconomic differences in model 18 
inputs, but not in an easy way to predict. This affirms the potential value for increasing the 19 
extent of formal and quantitative analysis of health inequality impacts to inform resource 20 
allocation decisions. Our study also suggests the need for better consideration of the diversity 21 
in deprivation structure, epidemiology and access to services across settings.   22 
 23 
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Tables 
 
Table 1. Category and concentration index of model inputs incorporating socioeconomic variation 
Category: Gradient in: Concentration index 
Background parameters 
(both models) 
Baseline quality-adjusted life expectancy 0.03 
Health opportunity costs -0.12 
Behaviours  
Smoking: prevalence  -0.08 
Alcohol:  abstention from drinking 0.06 
Alcohol:  average weekly consumption 0.03 
Alcohol:  peak day consumption 0.06 
Health consequences of 
behaviour 
Smoking: mortality  -0.08 
Alcohol:  mortality -0.07 
Smoking-related diseases -0.02 
Alcohol-related diseases -0.05 
Smoking: health-related quality of life  0.01 
Intervention 
characteristics  
Smoking: intervention effectiveness (quit smoking) 0.04 
Smoking: intervention uptake 0.17 
Alcohol: individuals screened for alcohol misuse -0.01 
Alcohol: probability of screening positive -0.01 
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Table 2. Estimates of impacts on overall health and health inequality in base case and scenario analysis 
  iNHB Change in iNHB 
from base case 
iEDE Change in iEDE 
from base case 
Inequality  
(iEDE-iNHB) 
Change in the impact on inequality  
compared to base case 
Smoking model (e-FLJDUHWWHYVµQRLQWHUYHQWLRQ¶    
Base case  80,782 - 70,002  -10,780 Increase inequality 
(a) Ignoring all gradients  80,510 -272 (-0.34%) 80,510 10,508 (15.01%) 0 Smaller increase 
(b) Ignoring gradient in: 
  Baseline QALE 80,782 0 (0%) 80,781 10,779 (15.40%) -1 Smaller increase  
  Health opportunity costs 80,782 0 (0%) 69,019 -983 (-1.40%) -11,763 Larger increase  
  Smoking prevalence 85,683 4,902 (6.07%) 69,454 -548 (-0.78%) -16,229 Larger increase 
  Mortality 79,543 -1,239 (-1.53%) 70,261 259 (0.37%) -9,282 Smaller increase  
  Smoking-related diseases 82,418 1,636 (2.03%) 70,853 851 (1.22%) -11,564 Larger increase 
  HRQoL 80,628 -153 (-0.19%) 70,053 51 (0.07%) -10,575 Smaller increase 
  Effectiveness 77,236 -3,546 (-4.39%)  69,942 -60 (-0.09%) -7,294 Smaller increase 
  Uptake 80,436 -345 (-0.43%) 81,463 11,461 (16.37%) 1,027 Inequality-reducing  
(c) Levelling up to the best in:   Effectiveness 88,229 7,448 (9.22%) 79,929 9,927 (14.18%) -8,300 Reduce  
  Uptake 109,656 28,875 (35.74%) 111,057 41,055 (58.65%) 1,400 Inequality-reducing 
Alcohol model µ1H[W5HJLVWUDWLRQ¶YVµQRLQWHUYHQWLRQ¶)       
Base case  4,336 - 4,780 - 444 Reduce inequality 
(a) Ignoring all gradients  4,083 -253 (-5.83%) 3,580 -1,199 (-25.08%) -503 Increases inequality 
(b) Ignoring gradient in: 
Baseline QALE 4,336 0 (0%) 4,336 -444 (-9.29%) 0 Smaller reduction 
Health opportunity costs 4,336 0 (0%) 4,989 209 (+4.37%) 652 Larger reduction 
Abstention  3,947 -389 (-8.97%) 4,125 -655 (-13.7%) 178 Smaller reduction 
Mortality 4,530 194 (+4.47%) 4,565 -215 (-4.5%) 35 Smaller reduction 
Alcohol-related diseases 4,856 519 (+11.97%) 4,645 -135 (-2.82%) -211 Increases inequality 
Average weekly consumption 5,092 756 (+17.44%) 6,253 1,474 (+30.84%) 1,162 Larger reduction 
Peak day consumption 4,724 388 (+8.95%) 5,421 642 (+13.43%) 698 Larger reduction 
Screening coverage 4,493 157 (+3.62%) 5,492 713 (+14.92%) 999 Larger reduction 
Screening positive (risky level) 4,803 466 (+10.75%) 5,512 732 (+15.31%) 709 Larger reduction 
(c) Levelling up to the best in: Screening rates (age-sex max) 4,817 480 (+11.07%) 6,213 1433 (+29.98%) 1,397 Larger reduction Screening rates (global max) 17,893 13,556 (+312.64%) 22,141 17361 (+363.2%) 4,248 Larger reduction 
QALE: quality-adjusted life expectancy 
HRQoL: health-related quality of life 
iNHB: incremental net health benefit 
iEDE: incremental equally distributed equivalent health 
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Figures 
 
Figure 1. Health equity impact plane* showing scenario analysis results where socioeconomic differences are ignored 
 
Figure 1a. Smoking model Figure 1b. Alcohol model 
  
 
*In the health equity plane, the y axis is the increase in population health and the x axis is the reduction in health inequality. Interventions that improve overall 
health fall in the north of the plane. Interventions that reduce inequality fall in the east of the plane. E-cigarette was estimated to increase overall health and 
increase inequality, so it locates in the north-west quadrDQWµ1H[W5HJLVWUDWLRQ¶ZDVHVWLPDWHGWRLQFUHDVHRYHUDOOKHDOWKDQGUHGXFHLQHTXDOLW\VRLWORFDWHVLQ
the north-east quadrant. 
 
Compared to the base case, if the location of the result in scenario analysis moves upward on the y axis, the model estimates more health improvement; if the 
location moves towards the right side on the x axis, the model estimates less inequality. For example, in the smoking model, the result of ignoring the 
socioeconomic difference in effectiveness moves downward and to the right, which indicates less health improvement and less inequality, compared to the base 
case.  
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Figure 2. Health equity impact plane* showing scenario analysis results where levelling up to the best 
 
Figure 2a. Smoking model Figure 2b. Alcohol model 
 
 
 
 
*Compared to the base case, if the location of the result in scenario analysis moves upward on the y axis, the model estimates more health improvement; if the 
location moves towards the right side on the x axis, the model estimates less inequality. For example, in the smoking model, the result of levelling up uptake 
moves upward and to the right, which indicates more health improvement and less inequality, compared to the base case. The loFDWLRQRIµXSWDNH¶LVLQWKH
north-east quadrant, indicating the intervention is estimated to reduce inequality.  
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Figure 3. Equity impact plane* showing the overall health and health inequality for Local Authority analysis 
 
Figure 3a. Smoking model Figure 3b. Alcohol model 
 
 
 
*Compared to the base case, if the location of the result in scenario analysis moves upward on the y axis, the model estimates more health improvement; if the 
location moves towards the right side on the x axis, the model estimates less inequality. For example, in the smoking model, the UHVXOWIRUµ6KHIILHOG¶PRYHV
XSZDUGDQGWRWKHOHIWZKLFKLQGLFDWHVPRUHKHDOWKLPSURYHPHQWDQGPRUHLQHTXDOLW\FRPSDUHGWRWKHUHVXOWIRUµ(QJODQG¶  
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Figure 4. Impact on health inequality vs. concentration index where socioeconomic differences are ignored 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4a. Smoking model  Figure 4b. Alcohol model 
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Appendices 
 
Table S1. Distribution of health opportunity costs by IMD quintile groups 
Parameter   Value  Source  
IMD1 (most deprived)  0.26 Love-Koh et al. (2016) (1) 
IMD2  0.22 
IMD3  0.22 
IMD4  0.16 
IMD5 (least deprived)  0.14 
IMD: Index of Multiple Deprivation 
 
 
Table S2. Distribution of the adult population of England 
 Adult population 
IMD1 (most deprived) 8,307,456 
IMD2 8,863,275 
IMD3 8,790,681 
IMD4 8,657257 
IMD5 (least deprived) 8,376,275 
IMD: Index of Multiple Deprivation 
 
 
Table S3. The social distribution of baseline QALE in England 
 QALE at birth (years) Source 
IMD1 (most deprived) 64.7 Love-Koh et al. (2015) (2) 
IMD2 68.5  
IMD3 70.6  
IMD4 73.6  
IMD5 (least deprived) 75.6  
IMD: Index of Multiple Deprivation 
QALE: quality-adjusted life expectancy 
 
 
Table S4. Smoking prevalence by IMD in England (2017) 
Smoking prevalence  Mean  95% confidence interval 
IMD1 (most deprived) 17.17% 16.55%, 17.79% 
IMD2 15.96% 15.22%, 16.70% 
IMD3 14.09% 13.24%, 14.95% 
IMD4 12.68% 11.80%, 13.57% 
IMD5 (least deprived) 11.38% 10.53%, 12.24% 
IMD: Index of Multiple Deprivation 
 
 
Table S5. Socioeconomic differences in drinking 
Deprivation quintile Abstention rate Average weekly consumption (units/drinker) 
Peak day consumption 
(units/drinker) 
IMD1 (most deprived) 28.2% 13.00 4.44 
IMD2 32.0% 12.01 3.96 
IMD3 14.1% 12.54 4.33 
IMD4 12.3% 13.63 5.11 
IMD5 (least deprived) 7.1% 14.95 5.71 
IMD: Index of Multiple Deprivation 
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Table S6. Output from HRQoL regression model using EQ-5D data from the Health Survey for 
England 2012 and 2014 
Variable 
 
Coefficient  Standard error  
Constant 
 
0.903*** 0.0139 
Age group 16-24 Ref  
 25-34 -0.0124*** 0.0137 
 35-44 -0.0544*** 0.0133 
 45-54 -0.0681*** 0.0135 
 55-64 -0.0986*** 0.0138 
 65-74 -0.107*** 0.0145 
 75+ -0.1630*** 0.0165 
Smoking status Former smoker Ref  
 Smoker  -0.0340*** 0.0069 
IMD IMD1 (most deprived) Ref 
  IMD2 0.0320** 0.0099 
 IMD3 0.0281** 0.0101 
 IMD4 0.0545*** 0.0102 
 IMD5 (least deprived) 0.0736*** 0.0101 
Adjusted R-squared 
 0.0414  
*p<0.05, **p<0.01, ***p<0.001 
IMD: Index of Multiple Deprivation 
HRQoL: health-related quality of life 
 
 
Table S7. Relative risk of quitting smoking 
Parameter  Value  95% confidence interval Distribution  Source  
IMD1 (most deprived) 1 -  Dobbie et al. 2015 (3) 
Grant 2014 (4) IMD2 1.35 0.94, 1.81 Lognormal*  
IMD3 1.22 0.79, 1.73 Lognormal*  
IMD4 1.27 0.91, 1.67 Lognormal*  
IMD5 (least deprived) 1.36 0.94, 1.82 Lognormal*  
*Estimates transformed to the log scale 
IMD: Index of Multiple Deprivation 
 
 
Table S8. Socioeconomic difference in screening rates in the alcohol model 
Deprivation quintile µ1H[W5HJLVWUDWLRQ¶VWUDWHJ\ Source  
IMD1 (most deprived) 9.4% Weir et al. 2017 (5) 
IMD2 12.6%  
IMD3 12.8%  
IMD4 11.2%  
IMD5 (least deprived) 11.1%  
IMD: Index of Multiple Deprivation 
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Table S9. Output from screening outcome regression model in the alcohol model from Alcohol 
Toolkit Study 
Variable 
 
Odds Ratio  
Standard 
Error 
Constant 
 
0.1226*** 0.0055 
Age group 16-24 Ref  
 25-34 0.4944*** 0.0216 
 35-54 0.2655*** 0.0105 
 55+ 0.0750*** 0.0035 
Sex Male Ref  
 Female  0.7267*** 0.0215 
Mean consumption (units/week) 
 1.2463*** 0.0029 
IMD IMD5 (least deprived) Ref  
 IMD4 1.1851*** 0.0436 
 IMD3 1.2540*** 0.0556 
 IMD2 1.2730*** 0.0668 
 IMD1 (most deprived) 1.7310*** 0.1120 
*p<0.05, **p<0.01, ***p<0.001 
Source: Beard et al. 2015 (6) 
IMD: Index of Multiple Deprivation 
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Figure S1. Socioeconomic difference in annual mortality risk for smokers 
 
IMD: Index of Multiple Deprivation 
 
 
Figure S2. Socioeconomic difference in annual mortality rate in the alcohol model* 
 
* extracted from Office for National Statistics (ONS) data 2012-2016 
IMD: Index of Multiple Deprivation 
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Figure S3. Population distribution according to IMD in York and Sheffield 
 
IMD: Index of Multiple Deprivation 
 
Figure S4. Population distribution according to IMD in Liverpool and Trafford 
 
IMD: Index of Multiple Deprivation 
 
 
Figure S5. Variation in socioeconomic difference in smoking prevalence for England, York and 
Sheffield 
 
IMD: Index of Multiple Deprivation 
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Figure S6. Variation in socioeconomic differences in model inputs for England, Liverpool and 
Trafford
 
 
 
IMD: Index of Multiple Deprivation 
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Figure S7. Impact on overall health vs. concentration index where socioeconomic differences are 
ignored 
Smoking model: e-FLJDUHWWHYVµQRLQWHUYHQWLRQ¶ 
 
 
Alcohol model1H[W5HJLVWUDWLRQYVµQRLQWHUYHQWLRQ¶ 
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